ACRIN 6684: Assessment of Tumor Hypoxia in Newly Diagnosed Glioblastoma Using F-18-FMISO PET and MRI

Authors :: Gerstner, ER
Zhang, Z
Fink, JR
Muzi, M
Hanna, L
Greco, E
Prah, M
Schmainda, KM
Mintz, A
Kostakoglu, L
Eikman, EA
Ellingson, BM
Ratai, E-M
Sorensen, AG
Barboriak, DP
Mankoff, DA
Grp, ACRINT
Source :: Gerstner, ER; Zhang, Z; Fink, JR; Muzi, M; Hanna, L; Greco, E; et al.(2016). ACRIN 6684: Assessment of Tumor Hypoxia in Newly Diagnosed Glioblastoma Using F-18-FMISO PET and MRI. CLINICAL CANCER RESEARCH, 22(20), 5079-5086. doi: 10.1158/1078-0432.CCR-15-2529. UCLA: Retrieved from: http://www.escholarship.org/uc/item/43x3n7w5
Publication Year :: 2016
Publisher :: eScholarship, University of California, 2016.

Language :: English
Database :: OpenAIRE
Journal :: Gerstner, ER; Zhang, Z; Fink, JR; Muzi, M; Hanna, L; Greco, E; et al.(2016). ACRIN 6684: Assessment of Tumor Hypoxia in Newly Diagnosed Glioblastoma Using F-18-FMISO PET and MRI. CLINICAL CANCER RESEARCH, 22(20), 5079-5086. doi: 10.1158/1078-0432.CCR-15-2529. UCLA: Retrieved from: http://www.escholarship.org/uc/item/43x3n7w5
Accession number :: edsair.od.......325..fbcc022db19b6a46cffdc13412cb5756
Full Text :: https://doi.org/10.1158/1078-0432.CCR-15-2529.

Full Text Access

Tools